Opinion: The RSV vaccine will help protect older adults from the respiratory virus
Getting the annual RSV shot and other important vaccines is a fantastic way to safeguard yourself and your family as winter ...
Medpage Today on MSN2d
Real-World Data on the RSV Vaccine for Older Adults
Regarding hospitalizations among immunocompetent older adults, vaccine effectiveness was 83% for the GSK vaccine and 73% for ...
The American Journal of Managed Care2h
Impact of RSV on Hospitalizations in US Adults Prior to Vaccine Introduction
Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...
cidrap.umn22h
Before RSV vaccine, virus caused substantial illness in US adults
A new study published today in JAMA Network Open shows that respiratory syncytial virus (RSV) was associated with a ...
The Daily News2d
RSV Vaccines for Older Adults (60+)
Respiratory syncytial virus, or RSV, is a virus that causes infections of the lungs and breathing passages. It is highly ...
Glamour on MSN10d
RSV Symptoms: Here’s How the Virus Shows Up Differently in Babies, Adults, and Seniors
Just like adults under 60, elderly adults who get RSV tend to have mild symptoms, such as runny nose, sore throat, cough, ...
Canada approves Moderna's RSV vaccine for adults aged 60 and older
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Canada approves Moderna's RSV vaccine for those age 60 and older, company says
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
EurekAlert!22h
Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023
In this cross-sectional study of adults hospitalized with respiratory syncytial virus (RSV) before the 2023 introduction of RSV vaccines, RSV was associated with substantial burden of hospitalizations ...
Monthly Prescribing Reference10d
RSV Vaccine Linked to Better Outcomes in Older Adults With IBD
Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.
Hosted on MSN6d
Year in Review: RSV
FDA Approvals and Expansions In May, the FDA approved the mRNA-1345 RSV vaccine (mResvia) from Moderna for people ages 60 and ...
Canada approves GSK's RSV vaccine for adults aged 50 to 59
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...